PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications | Molecular Cancer | Full Text
Olaparib Maintenance Therapy Delays Ovarian Cancer Progression - NCI
Asia Pacific Biotech News
PARP inhibitors in the management of breast cancer: current data and future prospects | BMC Medicine | Full Text
PARP Inhibitors Improve Outlook for Ovarian Cancer Patients | Ohio State Medical Center
What is a PARP Inhibitor? | Positive Bioscience
Biomedicines | Free Full-Text | Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance | HTML
PARP-Inhibitors in BRCA-Associated Pancreatic Cancer
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers | HTML
e Pathways underlying PARP-BRCA synthetic lethality. (A) | Download Scientific Diagram
Mechanism of sensitivity to PARP inhibition in BRCA-deficient cells SSB | Download Scientific Diagram
The Institute of Cancer Research - 🎉💊 This week marks the 25th anniversary of our discovery of the BRCA2 gene in 1995, which laid the groundwork for developing novel forms of therapy
File:BRCA PARP twohit.jpg - Wikimedia Commons
![PDF] PARP inhibitors in BRCA 1 / BRCA 2 germline mutation carriers with ovarian and breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8eb881023331f3a71fe973bfce9219e5d35bff3b/2-Figure1-1.png "PDF] PARP inhibitors in BRCA 1 / BRCA 2 germline mutation carriers with ovarian and breast cancer | Semantic Scholar")
PDF] PARP inhibitors in BRCA 1 / BRCA 2 germline mutation carriers with ovarian and breast cancer | Semantic Scholar
Cellular responses to DNA damage: mechanistic insights and clinical applications – Institute of Genetics and Cancer
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance | Experimental & Molecular Medicine
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
PARP inhibitors in ovarian cancer - Cancer Treatment Reviews
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review - Gynecologic Oncology
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells: Trends in Cell Biology
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer | Nature Reviews Clinical Oncology
